Professor Erika Lietzan has published a new article, Early Access to Unapproved Medicines in the United States and France, 19 Yale J. Health Pol’y L. & Ethics (2020). She, along with co-author Isabelle Moine-Dupuis, wrote about the new U.S. law on early access to experimental medicine. Lietzan and Moine-Dupuis explore the historical, legal, and cultural differences in the early access systems in both the U.S. and France.
Considering the French experience, the authors consider why experimental medicines may be more accessible in France and what might be needed to increase the use of these treatments in the U.S.